Return to Listing

1 result(s) for

PI Name Protocol # Title
Shivaani Kummar STUDY00021766 A Phase I/Ib Study to Evaluate the Safety, Tolerability, Biological and Clinical Activities of GEN-001 in Combination with Avelumab in Patients with Advanced Solid Tumors Who Have Progressed during or after Treatment with Anti-PD-(L)1 therapy

You may also qualify for Phase 1 Program trials.

For more information:
Call: 503-494-1080